Crispr Therapeutics shares owned by Hussman Econometrics Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Hussman Econometrics Advisors
from 13F filings
Historical chart of Hussman Econometrics Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Hussman Econometrics Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by Hussman Econometrics Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-09-30 | $422k | 9.3k | 45.39 |
2023-06-30 | $522k | 9.3k | 56.14 |
2023-03-31 | $751k | 17k | 45.23 |
2022-12-31 | $675k | 17k | 40.65 |
2022-09-30 | $680k | 10k | 65.38 |
2022-06-30 | $1.3M | 21k | 60.77 |
2022-03-31 | $653k | 10k | 62.79 |
2021-12-31 | $788k | 10k | 75.77 |
2021-09-30 | $1.4M | 12k | 111.94 |
2021-06-30 | $1.5M | 9.3k | 161.94 |
2021-03-31 | $439k | 3.6k | 121.94 |
2020-12-31 | $1.6M | 10k | 153.14 |
2020-09-30 | $2.6M | 31k | 83.63 |
2020-06-30 | $1.1M | 15k | 73.49 |
2020-03-31 | $651k | 15k | 42.41 |
2019-12-31 | $624k | 10k | 60.88 |
More positions owned by Hussman Econometrics Advisors
View all positions for Hussman Econometrics Advisors